Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography–tandem mass spectrometry
Lingzhi Wang, Rina Yue-Ling Ong, Tan‐Min Chin et al. · Journal of Pharmaceutical and Biomedical Analysis · 2011
Cited by 69 works. doi:10.1016/j.jpba.2011.11.034
Authors
- Lingzhi Wang
- Rina Yue-Ling Ong
- Tan‐Min Chin
- Win‐Lwin Thuya
- Seow‐Ching Wan
- Andrea Li‐Ann Wong
- Sui Yung Chan
- Paul C. Ho
- Boon-Cher Goh
References
- Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC−MS/MS
- Bioavailability of hydroxychloroquine tablets in healthy volunteers.
- Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography–tandem mass spectrometry
- Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
- Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritis
- Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused byPlasmodium vivax
- High-performance liquid chromatographic assay for hydroxychloroquine and metabolites in blood and plasma, using a stationary phase of poly(styrene divinylbenzene) and a mobile phase at ph 11, with fluorimetric detection
- Differential Metabolism of Gefitinib and Erlotinib by Human Cytochrome P450 Enzymes
- Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus
- Population Pharmacokinetics of Hydroxychloroquine in Patients With Rheumatoid Arthritis